Pharma industry grows more innovative

By Cai Wenjun | July 19, 2012, Thursday |

Online Edition

THE pharmaceutical industry in China is fast becoming more mature and professional, officials from Shanghai Food and Drug Administration told the China Pharmaceutical Sales and Marketing Excellence Summit ended in Shanghai today.

Already it is turning from a market-oriented model to clinical demand-oriented and turning from making imitation medicines to innovative drug development with own intellectual property rights, while the government and companies are increasing investment on research and development, officials said.

Launched by Global Intelligence Communications and the China International Health Industry Association, government officials and pharmaceutical companies gathered at the summit to discuss challenges and new trends in the industry.

With fewer profitable channels, government and regulatory spending pressures and the rising demand for return on investment, pharmaceutical companies are forced to change their business models and focus on development policies.

Metro

About Us
|
Terms of Use
|
RSS
|
Privacy Policy
|
Contact Us
|
Shanghai Call Center: 962288
|
Tip-off hotline: 52920043

沪ICP证：沪ICP备05050403号-1
|
互联网新闻信息服务许可证：31120180004
|
网络视听许可证：0909346
|
广播电视节目制作许可证：沪字第354号
|
增值电信业务经营许可证：沪B2-20120012

Pharma industry grows more innovative

Email this to your friend